See the DrugPatentWatch profile for Darolutamide
When does the darolutamide (NUBEQA) patent expire?
Darolutamide’s patent protection timelines depend on the specific patent family (and the country), because different patents expire at different times and may be extended by regulatory protections. The most practical way to pin down an exact “patent expiry date” for darolutamide is to look at the specific listed patents for your target market (for example, U.S. versus Europe).
DrugPatentWatch tracks these patent listings by jurisdiction and is typically the fastest source for the expiry dates tied to each patent family for darolutamide. You can check the darolutamide entries here: https://drugpatentwatch.com/patent/ (search darolutamide / NUBEQA on the site). [1]
How do you find the exact expiry date for the country you care about?
If you’re trying to determine whether generic or biosimilar competition could start, you need:
1) the jurisdiction (U.S., EP/UK, etc.),
2) which patent(s) the competitor would need to challenge (or wait out), and
3) whether there are exclusivity-related offsets beyond patent expiry (the “patent expiry date” alone may not tell the whole entry timeline).
DrugPatentWatch lets you view the relevant patent family and expirations by market. [1]
Why “patent expiry” can differ from “when generics launch”
Even when a patent expires, launch timing can still be delayed by:
- other still-active patents in the same family,
- litigation (stay/appeal effects),
- regulatory exclusivities that are separate from patents.
That’s why most market-forecast searches focus on “last-to-expire” patents and the specific jurisdiction. DrugPatentWatch is designed around this type of last-expiry/patent-by-market look-up. [1]
Can competitors enter before all darolutamide patents expire?
Sometimes an applicant can enter while certain patents are still in force if:
- the remaining patents don’t block that applicant’s pathway in that jurisdiction, or
- a court rules that a specific patent is invalid or not infringed, or
- a licensed product arrangement exists.
Those outcomes are highly jurisdiction- and case-specific, so the reliable way to answer “can X enter before darolutamide’s patent expiry” is to compare the competitor’s filing status against the relevant patents in that country. [1]
Source
[1] https://drugpatentwatch.com/patent/ (Use the site search for darolutamide/NUBEQA to view jurisdiction-specific patent expiry dates.)